Plain-English translation of NCT05752136 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new way to treat locally advanced rectal cancer. Researchers are combining three treatments before surgery: short-course radiation therapy (completed in one week), a newer immunotherapy medication called , and chemotherapy drugs. The goal is to shrink the tumor as much as possible before surgery and potentially help more patients avoid serious complications.
Current treatment plans for advanced rectal cancer don't always work well enough for all patients. This medication represents a newer approach that may help the body's immune system fight the cancer more effectively when combined with traditional radiation and chemotherapy.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive radiation therapy over one week (five daily treatments), followed by chemotherapy pills and injections combined with weekly shots of the new medication for about 2 cycles. After this combination therapy is complete, you will have surgery to remove the affected part of your rectum. Throughout treatment, you'll have regular blood tests and imaging scans to monitor how you're responding.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
China